Analysts See $0.35 EPS for BMC Stock Holdings (BMCH); Phaserx (PZRX) Shorts Lowered By 6.11%

October 12, 2017 - By Michael Collier

Analysts expect BMC Stock Holdings Inc (NASDAQ:BMCH) to report $0.35 EPS on November, 6.They anticipate $0.05 EPS change or 16.67% from last quarter’s $0.3 EPS. BMCH’s profit would be $23.39M giving it 14.64 P/E if the $0.35 EPS is correct. After having $0.34 EPS previously, BMC Stock Holdings Inc’s analysts see 2.94% EPS growth. The stock decreased 2.15% or $0.45 during the last trading session, reaching $20.5. About 860,786 shares traded or 95.45% up from the average. BMC Stock Holdings Inc (NASDAQ:BMCH) has 0.00% since October 12, 2016 and is . It has underperformed by 16.70% the S&P500.

Phaserx Incorporated (NASDAQ:PZRX) had a decrease of 6.11% in short interest. PZRX’s SI was 233,400 shares in October as released by FINRA. Its down 6.11% from 248,600 shares previously. With 37,200 avg volume, 6 days are for Phaserx Incorporated (NASDAQ:PZRX)’s short sellers to cover PZRX’s short positions. The SI to Phaserx Incorporated’s float is 4.59%. The stock increased 0.95% or $0.008 during the last trading session, reaching $0.885. About 45,934 shares traded. PhaseRx Inc (NASDAQ:PZRX) has 0.00% since October 12, 2016 and is . It has underperformed by 16.70% the S&P500.

PhaseRx, Inc is a biopharmaceutical firm developing a portfolio of mRNA products to correct life-threatening inherited liver diseases in children. The company has market cap of $10.35 million. The Company’s initial product development focus is on urea cycle disorders, a group of rare genetic diseases that generally present before the age of 12 and are characterized by the body’s inability to remove ammonia from the blood. It currently has negative earnings. The Company’s i-ERT approach is enabled by its Hybrid mRNA Technology platform and is applicable to a number of inherited liver diseases.

BMC Stock Holdings, Inc. is a provider of building services and products in the United States residential construction market. The company has market cap of $1.37 billion. The Company’s divisions include Mid-Atlantic, Southeast, Texas, Intermountain, Western and Mountain West divisions. It has a 33.62 P/E ratio. The Company’s product offerings include lumber and lumber sheet goods and an array of products, including millwork, doors, windows, structural components, floor and roof trusses and wall panels.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

>